Trump to Meet Privately With Disenchanted MAHA Leaders at White House

President Donald Trump convened a private roundtable Thursday at the White House with leaders of the Make America Healthy Again movement, a gathering designed less as a policy summit than as coalition triage. The meeting came at a moment of acute strain between Trump's governing apparatus and the MAHA bloc that helped deliver him a crucial constituency in 2024, with multiple flashpoints threatening to pull that alliance apart heading into the 2026 midterms.

The MAHA movement has become a wild card ahead of the midterm elections. The pressure on the White House to convene Thursday's session reflects how much electoral ground is now at stake. MAHA helped give Trump an important ally in Health and Human Services Secretary Robert F. Kennedy Jr., a longtime Democrat before he endorsed Trump and joined his administration, opening access to a new group of voters that Republicans consider key to holding the House this year.

The single most galvanizing grievance among disenchanted MAHA leaders is a February 18 executive order in which Trump invoked the Defense Production Act to boost domestic production of glyphosate, the herbicide used in Bayer-Monsanto's Roundup. Kennedy's MAHA coalition hated glyphosate, which has been alleged to cause cancer in myriad lawsuits, and the executive order threatened to unravel that coalition ahead of the midterms. Zen Honeycutt, leader of Moms Across America, warned that Republicans were facing their biggest setback yet with the MAHA movement after Trump signed the order, calling it the biggest uproar the movement had seen.

Kennedy himself barely concealed his frustration. He told podcast host Joe Rogan in February, "It's not something that I was particularly happy with. Let me put it that way, mildly." MAHA influencer Vani Hari, who has 2.3 million Instagram followers, said the government had handed Bayer "a license" to continue harming Americans. Alex Clark, a MAHA podcast host with Turning Point USA, reported receiving a flood of messages from women abandoning the Republican Party.

HHS Secretary Kennedy over the last several months has suffered a series of setbacks that have sapped his influence within the GOP and left him diminished within the Trump administration. A Kennedy-led strategy to address chronic disease skipped calls for pesticide bans and restrictions, with the White House cooling on Kennedy's aggressive vaccine policies as well. The administration has also moved to install a seasoned political operative as Kennedy's deputy, with a mandate to steer HHS toward less contentious priorities before November.

The stalled nomination of surgeon general pick Casey Means adds another layer to Thursday's meeting. The nomination of Means, a Stanford-trained physician and wellness author, appears stuck in the Senate, with Republican senators including Lisa Murkowski and Bill Cassidy among those expressing reservations, a development seen as the latest sign that some Republicans have reached their limit on the more divisive aspects of the MAHA agenda.

Trump's top pollster, Tony Fabrizio, cautioned in December that an embrace of Kennedy's anti-vaccine policies could cost politicians their jobs in 2026, pointing to his own poll of 1,000 voters across 35 competitive districts that found eight in ten MAHA voters and 86 percent of all voters believe vaccines save lives.

That data captures the bind Trump faces: the MAHA base wants aggressive action on pesticides, food additives, and pharmaceutical influence, while the broader electorate recoils from the movement's more polarizing positions. With court losses mounting, key nominations stalled, and the CDC still operating without permanent leadership as of late March, the near-term direction of the MAHA agenda remains genuinely unclear. Thursday's closed-door session was Trump's attempt to keep enough of that coalition in place long enough to make it through November.